When do the new level II codes Q5108 and Q5110 take effect?
The effective date for code Q5108–injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg—is July 12, 2018. For Q5110–injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram—the effective date is October 1, 2018. The implementation date for both codes is October 1, 2018. This information can be found at https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/2018Downloads/R4134CP.pdf.